ýҕl

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • ýҕl Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

WHAT'S NEW

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, Aug 18 2021

Full Issue

'We Just Have To All Agree That This Isn't Working': Drug-Pricing Reform Faces 'Pivotal' Moment On Capitol Hill

Read about the biggest pharmaceutical developments and pricing stories from the past week in KHN's Prescription Drug Watch roundup.

Drug prices are once again in focus on Capitol Hill as lawmakers renew their push for pricing reform. And U.S. Health and Human Services Department Sec. Xavier Becerra has joined in on the effort. "We just have to all agree that this isn't working. Countries around the world are providing medicine to their people for far less than we do," Becerra told Yahoo Finance in an exclusive interview Monday, adding that often those same drugs are made in the U.S. Becerra made an appearance alongside U.S. Rep. Frank Pallone (D-NJ-06) and U.S. Sen. Cory Booker (D-NJ) in New Jersey Monday at a multi-city event to discuss lower drug costs. (Khemlani, 8/17)

If there was any doubt about the sincerity President Joe Biden wanted to convey with his appeal to Congress on drug pricing reform, he removed it by bringing his departed mom into the discussion. Speaking in the East Room of the White House on Thursday, Biden recalled that Catherine Biden’s “prescription drugs were so expensive” that it took money from himself, his two brothers and a sister to cover the cost so she wouldn’t have to “exhaust the little savings she had.” With that, Biden set the scene for what promises to be a contentious several weeks in Washington as Congress weighs potential measures to combat high drug costs. (Dunleavy, 8/16)

On Monday, AARP launched a three-week television, and radio advertising campaign urging U.S. Senators to support allowing Medicare to use its power to negotiate drug prices with drug manufacturers. The seven-figure investment highlights negotiation as a critical step toward lowering prescription drug costs for all Americans, especially seniors who on average take between four and five medications each month and have a median income of just over $26,000 a year, AARP said. (Nylander, 8/16)

Governor JB Pritzker Monday signed a package of legislation that aims to address financial obstacles in accessing health care, while increasing transparency when purchasing prescription medications. HB 119 formalizes the legal process for donating unused prescription drugs to certified pharmacies or health departments. By establishing a prescription drug repository program, prescription and over-the-counter medication that remain unexpired and unopened can be returned to pharmacies and reused for eligible populations. (8/17)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, June 12
  • Thursday, June 11
  • Wednesday, June 10
  • Tuesday, June 9
  • Monday, June 8
  • Friday, June 5
More Morning Briefings
RSS Feeds
  • ýҕl
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF